ARCHIVES

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 16 No. 06 | February 9, 1990

Download PDF Visit The Full Archive

Related Articles

New Mexico, Michigan Win Saturation Implementation Contracts

June 6, 1975

In Brief: Rosenthal Names ACS President; Brown, Lynch, Mintz Win ACS Medals of Honor

November 14, 1997

ACS Says NCI Needs $1.1 Billion, Cites Progress In Prevention, Control

April 29, 1977

NCI Launches NCORP with 53 Grants Totaling $465 Million

August 8, 2014

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

NCI Encourages New Regional Cooperative Groups

November 19, 1976